{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T14:40:02Z","timestamp":1755873602783,"version":"3.44.0"},"publisher-location":"New York, NY, USA","reference-count":43,"publisher":"ACM","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,20]]},"DOI":"10.1145\/3644116.3644275","type":"proceedings-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T18:38:22Z","timestamp":1712342302000},"page":"927-930","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Progress and prospect of artificial intelligence in the diagnosis and treatment of liver cancer"],"prefix":"10.1145","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7349-445X","authenticated-orcid":false,"given":"Jianhao","family":"Yu","sequence":"first","affiliation":[{"name":"Jilin International Studies University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8012-6425","authenticated-orcid":false,"given":"Zhenyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Jilin International Studies University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7951-8017","authenticated-orcid":false,"given":"Zhiyang","family":"Jin","sequence":"additional","affiliation":[{"name":"Jilin International Studies University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"320","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"e_1_3_2_1_1_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i36.5515"},{"key":"e_1_3_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.4842"},{"key":"e_1_3_2_1_3_1","doi-asserted-by":"publisher","unstructured":"Zhang Y Xi Y Fang J Luo S Wilson JJ Huang RP. Identification and characterization of monoclonal antibodies against GP73 for use as a potential biomarker in liver cancer screening and diagnosis. J Immunoassay Immunochem. 2016;37(4):390-406. doi: 10.1080\/15321819.2016.1154866. PMID: 27088654.","DOI":"10.1080\/15321819.2016.1154866"},{"key":"e_1_3_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0408928102"},{"key":"e_1_3_2_1_5_1","doi-asserted-by":"publisher","unstructured":"Testoni B Leboss\u00e9 F Scholtes C Berby F Miaglia C Subic M Loglio A Facchetti F Lampertico P Levrero M Zoulim F. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients. J Hepatol. 2019 Apr;70(4):615-625. doi: 10.1016\/j.jhep.2018.11.030. Epub 2018 Dec 7. PMID: 30529504.","DOI":"10.1016\/j.jhep.2018.11.030"},{"key":"e_1_3_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920901)70:5<1044::AID-CNCR2820700506>3.0.CO;2-U"},{"key":"e_1_3_2_1_7_1","doi-asserted-by":"publisher","unstructured":"Qin QF Weng J Xu GX Chen CM Jia CK. Combination of serum tumor markers dickkopf-1 DCP and AFP for the diagnosis of primary hepatocellular carcinoma. Asian Pac J Trop Med. 2017 Apr;10(4):409-413. doi: 10.1016\/j.apjtm.2017.03.016. Epub 2017 Apr 6. PMID: 28552111.","DOI":"10.1016\/j.apjtm.2017.03.016"},{"key":"e_1_3_2_1_8_1","doi-asserted-by":"publisher","unstructured":"Liu Z Wu M Lin D Li N. Des-gamma-carboxyprothrombin is a favorable biomarker for the early diagnosis of alfa-fetoprotein-negative hepatitis B virus-related hepatocellular carcinoma. J Int Med Res. 2020 Feb;48(2):300060520902575. doi: 10.1177\/0300060520902575. PMID: 32054358; PMCID: PMC7111028.","DOI":"10.1177\/0300060520902575"},{"key":"e_1_3_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601543"},{"key":"e_1_3_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(01)00445-1"},{"issue":"5","key":"e_1_3_2_1_11_1","first-page":"433","article-title":"Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation [J]","volume":"75","author":"Kato H","year":"1984","unstructured":"Kato H, Nagaya T, Torigoe T. Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation [J]. Gann, 1984, 75(5): 433-435.","journal-title":"Gann"},{"key":"e_1_3_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M307741200"},{"key":"e_1_3_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000030042"},{"key":"e_1_3_2_1_14_1","doi-asserted-by":"crossref","unstructured":"Glinka A Wu W Delius H Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 1998; 391:357\u201362.","DOI":"10.1038\/34848"},{"key":"e_1_3_2_1_15_1","doi-asserted-by":"crossref","unstructured":"Choi YW Park JS Han JH Strong immunoexpression of dickkopf1 is associated with response to bortezomib in multiple myeloma. Leuk Lymphoma 2018; 59:2670\u20138.","DOI":"10.1080\/10428194.2018.1443331"},{"key":"e_1_3_2_1_16_1","doi-asserted-by":"crossref","unstructured":"Pamuk GE Uyanik MS Pamuk ON Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in nonHodgkin's lymphoma at initial diagnosis: could they be playing roles in pathogenesis? Hematology 2015; 20:267\u201371.","DOI":"10.1179\/1607845414Y.0000000205"},{"key":"e_1_3_2_1_17_1","doi-asserted-by":"crossref","unstructured":"Liu Z Sun B Qi L Dickkopf-1 expression is down-regulated during the colorectal adenoma-carcinoma sequence and correlates with reduced microvessel density and VEGF expression. Histopathology 2015; 67: 158\u201366.","DOI":"10.1111\/his.12474"},{"key":"e_1_3_2_1_18_1","volume-title":"Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. Oncotarget 2015","author":"Han SX","year":"1990","unstructured":"Han SX, Zhou X, Sui X, Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. Oncotarget 2015; 6:19907\u201317"},{"key":"e_1_3_2_1_19_1","doi-asserted-by":"crossref","unstructured":"Sakabe T Azumi J Umekita Y Expression of cancer stem cellassociated DKK1 mRNA serves as prognostic marker for hepatocellular carcinoma. Anticancer Res 2017; 37:4881\u20138.","DOI":"10.21873\/anticanres.11897"},{"key":"e_1_3_2_1_20_1","volume-title":"Dickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway. Oncotarget 2017","author":"Choi SH","year":"2015","unstructured":"Choi SH, Kim H, Lee HG, Dickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway. Oncotarget 2017; 8:58974\u201384. [20] Liang L, He H, Lv R, Preliminary mechanism on the methylation modification of Dkk-1 and Dkk-3 in hepatocellular carcinoma. Tumour Biol 2015;36:1245\u201350."},{"key":"e_1_3_2_1_21_1","doi-asserted-by":"crossref","unstructured":"Huang Y Yang X Zhao F Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence. Med Oncol 2014; 31:966.","DOI":"10.1007\/s12032-014-0966-8"},{"key":"e_1_3_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70233-4"},{"key":"e_1_3_2_1_23_1","doi-asserted-by":"crossref","unstructured":"Yang H Chen GD Fang F Dickkopf-1: as a diagnostic and prognostic serum marker for early hepatocellular carcinoma. Int J Biol Markers 2013; 28:286\u201397.","DOI":"10.5301\/JBM.5000015"},{"key":"e_1_3_2_1_24_1","doi-asserted-by":"crossref","unstructured":"Shen Q Fan J Yang XR Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale multicentre study. Lancet Oncol 2012; 13:817\u201326.","DOI":"10.1016\/S1470-2045(12)70233-4"},{"key":"e_1_3_2_1_25_1","volume-title":"TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma. PLoS One 2017","author":"Mao L","year":"1838","unstructured":"Mao L, Wang Y. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma. PLoS One 2017; 12:e0183880."},{"key":"e_1_3_2_1_26_1","doi-asserted-by":"crossref","unstructured":"Jang ES Jeong SH Kim JW Diagnostic performance of alphafetoprotein protein induced by vitamin K absence osteopontin dickkopf-1 and its combinations for hepatocellular carcinoma. PLoS One 2016; 11:e0151069.","DOI":"10.1371\/journal.pone.0151069"},{"key":"e_1_3_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206832"},{"key":"e_1_3_2_1_28_1","doi-asserted-by":"publisher","unstructured":"Yang H Xiong FX Lin M LAPTM4B-35 is a novel diagnostic marker and a prognostic factor of hepatocellular carcinoma. J Surgical Oncology. 2010; 101(5):363\u2013369. doi: 10.1002\/jso.21489.","DOI":"10.1002\/jso.21489"},{"key":"e_1_3_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-009-0659-4"},{"key":"e_1_3_2_1_30_1","doi-asserted-by":"publisher","unstructured":"Li L Shan Y Yang H Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line. Anat Rec (Hoboken) 2011; 294(7):1135\u20131142. doi: 10.1002\/ar.21421.","DOI":"10.1002\/ar.21421"},{"key":"e_1_3_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2009.01346.x"},{"key":"e_1_3_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.19723\/j.issn.1671-167X.2021.04.015"},{"issue":"2","key":"e_1_3_2_1_33_1","article-title":"Hepatocyte growth factor has potent anti\u2010proliferative activity in various tumor cell lines [J]","volume":"291","author":"Matsumoto Kunio","year":"1991","unstructured":"Matsumoto Kunio,Nakamura Toshikazu,Tajima Hisao. Hepatocyte growth factor has potent anti\u2010proliferative activity in various tumor cell lines [J]. FEBS Letters, 1991, 291(2)","journal-title":"FEBS Letters"},{"key":"e_1_3_2_1_34_1","article-title":"Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue. [J]","volume":"20","author":"Beppu K","year":"2000","unstructured":"Beppu K,Uchiyama A,Morisaki T,Nakamura K,Noshiro H,Matsumoto K,Nakamura T,Tanaka M,Katano M. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue. [J]. Anticancer Research: International Journal of Cancer Research and Treatment, 2000, 20(2B)","journal-title":"Anticancer Research: International Journal of Cancer Research and Treatment"},{"key":"e_1_3_2_1_35_1","doi-asserted-by":"publisher","unstructured":"Yamagamim H Moriyama M Matsumura H Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases. Cancer. 2002; 95(4):824-834. doi:10.1002\/cncr.10732","DOI":"10.1002\/cncr.10732"},{"key":"e_1_3_2_1_36_1","volume-title":"Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. [J]. Nature reviews Cancer","author":"Bierie B","year":"2006","unstructured":"Bierie B,Moses HL. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. [J]. Nature reviews Cancer, 2006, 6(7)"},{"key":"e_1_3_2_1_37_1","volume-title":"Cell","author":"Massague J.","year":"2008","unstructured":"Massague J. TGF beta in cancer [J]. Cell, 2008, 134(2)."},{"key":"e_1_3_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118055"},{"key":"e_1_3_2_1_39_1","doi-asserted-by":"crossref","unstructured":"Shirai Yasuhiro \u201cPlasma transforming growth factor\u2010\u03b21 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases.\u201d Cancer 73 (1994): n. pag.","DOI":"10.1002\/1097-0142(19940501)73:9<2275::AID-CNCR2820730907>3.0.CO;2-T"},{"key":"e_1_3_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206624"},{"issue":"3","key":"e_1_3_2_1_41_1","first-page":"999","article-title":"Novel oncogene HCCR: its diagnostic and therapeutic implications for cancer [J]","volume":"20","author":"Chung YJ","year":"2005","unstructured":"Chung YJ, Kim JW. Novel oncogene HCCR: its diagnostic and therapeutic implications for cancer [J], Histol Histopathol, 2005, 20 (3): 999-1003","journal-title":"Histol Histopathol"},{"key":"e_1_3_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.03.055"},{"key":"e_1_3_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207356"}],"event":{"name":"ISAIMS 2023: 2023 4th International Symposium on Artificial Intelligence for Medicine Science","acronym":"ISAIMS 2023","location":"Chengdu China"},"container-title":["Proceedings of the 2023 4th International Symposium on Artificial Intelligence for Medicine Science"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3644116.3644275","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3644116.3644275","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T14:12:02Z","timestamp":1755871922000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3644116.3644275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":43,"alternative-id":["10.1145\/3644116.3644275","10.1145\/3644116"],"URL":"https:\/\/doi.org\/10.1145\/3644116.3644275","relation":{},"subject":[],"published":{"date-parts":[[2023,10,20]]},"assertion":[{"value":"2024-04-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}